Trading Ideas http://www.benzinga.com/views/taxonomy/term/22 en Oppenheimer Has High Hopes For Lululemon Going Into Q2 Results http://www.benzinga.com/analyst-ratings/analyst-color/16/08/8390626/oppenheimer-has-high-hopes-for-lululemon-going-into-q2-r <p>A week ahead of the earnings announcement from <strong>Lululemon Athletica inc.</strong> (NASDAQ: <a class="ticker" href="http://www.benzinga.com/stock/lulu#NASDAQ">LULU</a>), Oppenheimer remains bullish on the second-quarter results. Analyst Anna Andreeva maintains an Outperform rating on the stock.</p> <p>The brokerage&#039;s confidence is due to the improvements in industry average demand compared to the first quarter. Andreeva pointed out sales have advanced 1 percent sequentially. The company&#039;s history of beating sales guidance also boosted sentiments. Sales topped guidance in the last five of the six quarters. Therefore, expectations remain high that Lululemon&#039;s second-quarter top line will exceed the expectations.</p> <p>"We think product execution keeps improving (better balance in tops across price points; last year&#039;s pant wall launch is being lapped with expanded Align ...</p><p><a href=http://www.benzinga.com/analyst-ratings/analyst-color/16/08/8390626/oppenheimer-has-high-hopes-for-lululemon-going-into-q2-r alt=Oppenheimer Has High Hopes For Lululemon Going Into Q2 Results>Full story available on Benzinga.com</a></p> Analyst Color Anna Andreeva Earnings Long Ideas LULU News Oppenheimer Previews Reiteration Analyst Ratings Movers Trading Ideas LULU US5500211090 Long Ideas News Analyst Color Earnings Previews Reiteration Analyst Ratings Movers Trading Ideas Benzinga Thu, 25 Aug 2016 15:35:22 +0000 R. Chandrasekaran 8390626 at http://www.benzinga.com Rising Street Value Of ResMed Shares Disconnected From Its Fundamentals http://www.benzinga.com/analyst-ratings/analyst-color/16/08/8390879/rising-street-value-of-resmed-shares-disconnected-from-i <p> The stock valuation for <b>ResMed Inc.</b> (NYSE: <a class="ticker" href="http://www.benzinga.com/stock/rmd#NYSE">RMD</a>) and its share price have increased despite the company&rsquo;s deteriorating fundamentals.</p> <p> Barclays&rsquo; Matthew Taylor maintained an Underweight rating on the company, with a price target of $55.</p> <h3> Headwinds</h3> <p> &ldquo;While sleep apnea is a good volume market and we think RMD was intelligent to diversify away from some of its core pressures, we think there are headwinds coming in FY17 that even recent acquisitions and a good management team will have trouble managing through,&rdquo; Taylor mentioned.</p> <p> The analyst pointed out several factors that were likely to negatively impact ResMed in the near future, including slower ...</p><p><a href=http://www.benzinga.com/analyst-ratings/analyst-color/16/08/8390879/rising-street-value-of-resmed-shares-disconnected-from-i alt=Rising Street Value Of ResMed Shares Disconnected From Its Fundamentals>Full story available on Benzinga.com</a></p> Analyst Color Barclays Matthew Taylor RMD Short Ideas Reiteration Analyst Ratings Trading Ideas RMD US7611521078 Analyst Color Short Ideas Reiteration Analyst Ratings Trading Ideas Benzinga Thu, 25 Aug 2016 15:30:54 +0000 Jim Swanson 8390879 at http://www.benzinga.com Some Silver Linings For Williams-Sonoma Offered By Baird http://www.benzinga.com/analyst-ratings/analyst-color/16/08/8390798/some-silver-linings-for-williams-sonoma-offered-by-baird <p> <b>Williams-Sonoma, Inc.</b> (NYSE: <a class="ticker" href="http://www.benzinga.com/stock/wsm#NYSE">WSM</a>) reported in-line EPS for Q2, while lowering its FY16 guidance by 3.5 percent at the midpoint, driven by a softer retail environment.</p> <p> Baird&rsquo;s Peter S. Benedict maintained an Outperform rating on the company, while lowering the price target from $68 to $61.</p> <h3> Disappointing Results &amp; Guidance</h3> <p> &ldquo;While the guidance reset reinforces concerns around the revenue/margin trajectory at WSM, expectations were low, and there were some silver linings in the print,&rdquo; Benedict mentioned.</p> <p> Sales declined during the quarter, missing expectations, although improvements in shipping and fulfillment related costs and tight expense control led to in-line EPS of $0.58.</p> <p> Top line trend also slowed during the quarter, with comps slowing to 0.6 percent, from the ...</p><p><a href=http://www.benzinga.com/analyst-ratings/analyst-color/16/08/8390798/some-silver-linings-for-williams-sonoma-offered-by-baird alt=Some Silver Linings For Williams-Sonoma Offered By Baird>Full story available on Benzinga.com</a></p> Analyst Color Baird Long Ideas Peter S. Benedict WSM Price Target Analyst Ratings Trading Ideas WSM US9699041011 Long Ideas Analyst Color Price Target Analyst Ratings Trading Ideas Benzinga Thu, 25 Aug 2016 15:30:14 +0000 Jim Swanson 8390798 at http://www.benzinga.com Williams-Sonoma Holds Onto An Outperform Rating At Oppenheimer On Long-Term Outlook http://www.benzinga.com/analyst-ratings/analyst-color/16/08/8390577/williams-sonoma-holds-on-to-an-outperform-rating-at-oppe <p>On Wednesday after the market close, <b>Williams-Sonoma, Inc.</b> (NYSE: <a class="ticker" href="http://www.benzinga.com/stock/wsm#NYSE">WSM</a>) <a href="http://www.benzinga.com/analyst-ratings/analyst-color/16/08/8388950/pottery-barn-follows-furnishing-industry-slump-williams-">reported earnings</a> mirroring analyst estimates but missed on revenues and comparable sales. In addition, company management&rsquo;s weak forecasts spooked investors.</p> <h3>Tough Environment</h3> <p>Oppenheimer&rsquo;s Brian Nagel viewed Williams-Sonoma weak Q2 earnings report as a result of a &ldquo;challenging macro backdrop and potential merchandising shortcomings at the chain&rsquo;s leading brands.&rdquo;</p> <p>The analyst remained encouraged with shares eventually shaking off Q2 weakness but was concerned with furnishings category in the near term.</p> <p><bzrelatedlink>Related Link: <a href="http://www.benzinga.com/analyst-ratings/analyst-color/16/08/8390338/morgan-stanley-shows-concern-for-williams-sonomas-margin">Morgan Stanley Shows ...</a></bzrelatedlink></p><p><a href=http://www.benzinga.com/analyst-ratings/analyst-color/16/08/8390577/williams-sonoma-holds-on-to-an-outperform-rating-at-oppe alt=Williams-Sonoma Holds Onto An Outperform Rating At Oppenheimer On Long-Term Outlook>Full story available on Benzinga.com</a></p> Analyst Color Brian Nagel Earnings Long Ideas News Oppenheimer WSM Guidance Price Target Reiteration Analyst Ratings Movers Trading Ideas WSM US9699041011 Long Ideas News Analyst Color Earnings Guidance Price Target Reiteration Analyst Ratings Movers Trading Ideas Benzinga Thu, 25 Aug 2016 14:42:16 +0000 Andrew Efimoff 8390577 at http://www.benzinga.com Mallinckrodt Nuclear Biz Sale A Positive In BMO's View, Maintains Outperform http://www.benzinga.com/analyst-ratings/analyst-color/16/08/8390552/mallinckrodt-nuclear-biz-sale-a-positive-in-bmos-view-ma <p>BMO Capital&rsquo;s Gary Nachman believes the recently announced sale of the nuclear imaging business by <b>Mallinckrodt PLC</b> (NYSE: <a class="ticker" href="http://www.benzinga.com/stock/mnk#NYSE">MNK</a>) might be dilutive to the company&rsquo;s EPS but is likely to be accretive to the company&rsquo;s overall growth and margins.</p> <p>Nachman reiterated an Outperform rating on the company with a price target of $93.</p> <h3>Impact Of Sale</h3> <p>&ldquo;As a result of this transaction we are moving the nuclear business from MNK&#39;s continuing operations into discontinued ops beginning calendar 3Q16. This removes revenue of roughly $400 million per year at an operating margin of roughly 20&ndash;30 percent,&rdquo; ...</p><p><a href=http://www.benzinga.com/analyst-ratings/analyst-color/16/08/8390552/mallinckrodt-nuclear-biz-sale-a-positive-in-bmos-view-ma alt=Mallinckrodt Nuclear Biz Sale A Positive In BMO&#039;s View, Maintains Outperform>Full story available on Benzinga.com</a></p> Analyst Color Biotech BMO Capital Markets Gary Nachman Long Ideas MNK Health Care Reiteration Analyst Ratings Trading Ideas General MNK Long Ideas Analyst Color Biotech Health Care Reiteration Analyst Ratings Trading Ideas General Benzinga Thu, 25 Aug 2016 14:33:46 +0000 Jim Swanson 8390552 at http://www.benzinga.com Why Mobileye Investors Could Be The Biggest Winners In The Autonomous Auto Race http://www.benzinga.com/analyst-ratings/analyst-color/16/08/8390759/why-mobileye-investors-could-be-the-biggest-winners-in-t <p>The race to create the world&rsquo;s first fully autonomous vehicle is still in its infancy, with <strong>Ford Motor Company</strong> (NYSE: <a class="ticker" href="http://www.benzinga.com/stock/f#NYSE">F</a>), <strong>General Motors Company</strong> (NYSE: <a class="ticker" href="http://www.benzinga.com/stock/gm#NYSE">GM</a>), <strong>Tesla Motors Inc</strong> (NASDAQ: <a class="ticker" href="http://www.benzinga.com/stock/tsla#NASDAQ">TSLA</a>) and even <strong>Alphabet Inc</strong> (NASDAQ: <a class="ticker" href="http://www.benzinga.com/stock/goog#NASDAQ">GOOG</a>) (NASDAQ: <a class="ticker" href="http://www.benzinga.com/stock/googl#NASDAQ">GOOGL</a>) in on the competition. There seems to be little question that automation is the next step in the auto industry. However, at this point, it&rsquo;s too early to pick a winner.</p> <p>There&rsquo;s an old saying that the people who get the richest during gold rushes are the ones selling shovels. In the world of automated vehicles, vision-based driving systems technology company <strong>Mobileye NV</strong> (NYSE: <a class="ticker" href="http://www.benzinga.com/stock/mbly#NYSE">MBLY</a>) is the shovel salesman.</p> <p>Mobileye recently announced a new ...</p><p><a href=http://www.benzinga.com/analyst-ratings/analyst-color/16/08/8390759/why-mobileye-investors-could-be-the-biggest-winners-in-t alt=Why Mobileye Investors Could Be The Biggest Winners In The Autonomous Auto Race>Full story available on Benzinga.com</a></p> Analyst Color Autonomous Cars Autonomous Driving autonomous vehicles Baird BMWYY David Leiker DLPH Dougherty & CompanyBarclays F GM GOOG GOOGL JPMorgan Long Ideas MBLY self-driving self-driving cars self-driving vehicles TSLA Top Stories Analyst Ratings Tech Trading Ideas GOOG US38259P7069 F US3453708600 GM US37045V1008 TSLA US88160R1014 DLPH GOOGL US38259P5089 MBLY BMWYY Long Ideas Analyst Color Top Stories Analyst Ratings Tech Trading Ideas Benzinga Thu, 25 Aug 2016 14:16:49 +0000 Wayne Duggan 8390759 at http://www.benzinga.com The Industry Implications Of A Possible All-Glass Apple '360 Degree' iPhone http://www.benzinga.com/analyst-ratings/analyst-color/16/08/8390632/the-industry-implications-of-a-possible-all-glass-apple- <p>Next year, <strong>Apple Inc.</strong> (NASDAQ: <a class="ticker" href="http://www.benzinga.com/stock/aapl#NASDAQ">AAPL</a>) will celebrate the 10-year anniversary of the most successful product of all time &mdash; the iPhone. Several news sources have reported that Apple may choose to make a big design splash by opting for a glass back and/or curved edges that would enable new functionality.</p> <p>Goldman Sachs analyst Doug Clark recently discussed the market impact of an all-glass iPhone. According to Clark, Goldman&rsquo;s base case still calls for the 2017 device to have its standard metal back, but the firm is also preparing for two contingencies: 1) glass casings for high-end 5.5&rdquo; or larger models and 2) ...</p><p><a href=http://www.benzinga.com/analyst-ratings/analyst-color/16/08/8390632/the-industry-implications-of-a-possible-all-glass-apple- alt=The Industry Implications Of A Possible All-Glass Apple &#039;360 Degree&#039; iPhone>Full story available on Benzinga.com</a></p> 360 degree iPhone AAPL Analyst Color Apple 360 Biel Crystal Catcher GLW iPhone Lens Technology Long Ideas News Rumors Analyst Ratings Tech Trading Ideas AAPL US0378331005 GLW US2193501051 Long Ideas News Analyst Color Rumors Analyst Ratings Tech Trading Ideas Benzinga Thu, 25 Aug 2016 14:08:04 +0000 Wayne Duggan 8390632 at http://www.benzinga.com Infinera Shares Lower As Citi Downgrades To Sell http://www.benzinga.com/analyst-ratings/analyst-color/16/08/8390463/infinera-shares-lower-as-citi-downgrades-to-sell <p><strong>Infinera Corp.</strong> (NASDAQ: <a class="ticker" href="http://www.benzinga.com/stock/infn#NASDAQ">INFN</a>) earnings have provided a positive surprise between 5.0 percent and 29.4 percent in the last four quarters. Its most recent quarter&#039;s EPS topped by $0.03, or 16.7 percent. However, that did not deter Citi from downgrading the stock from Neutral to Sell and slashing the price objective from $10 to $8, which subsequently sent the stock lower on Thursday.</p> <p>Analysts Stanley Kovler and Brendan Finn reached their conclusion based on a 22x profit earnings ratio applied to their EPS estimate of $0.36 for the fiscal year 2017, which was lower than the Street&#039;s consensus of $0.42. The analysts cited the recent volatility in the stock and termed it ...</p><p><a href=http://www.benzinga.com/analyst-ratings/analyst-color/16/08/8390463/infinera-shares-lower-as-citi-downgrades-to-sell alt=Infinera Shares Lower As Citi Downgrades To Sell>Full story available on Benzinga.com</a></p> Analyst Color Brendan Finn Citi INFN Stanley Kovler Short Ideas Downgrades Price Target Analyst Ratings Tech Trading Ideas INFN US45667G1031 Analyst Color Short Ideas Downgrades Price Target Analyst Ratings Tech Trading Ideas Benzinga Thu, 25 Aug 2016 14:03:47 +0000 R. Chandrasekaran 8390463 at http://www.benzinga.com HP Inc's Reinvestments Set Up A Strong 2017 http://www.benzinga.com/analyst-ratings/analyst-color/16/08/8390297/hp-incs-reinvestments-set-up-a-strong-2017 <p><b>HP Inc</b> (NYSE: <a class="ticker" href="http://www.benzinga.com/stock/hpq#NYSE">HPQ</a>) reported better-than-expected revenue, EPS and free cash flow for the July quarter, while lowering its FY16 EPS guidance to reflect plans to invest in additional hardware units to support long-term printer supplies growth.</p> <p>Morgan Stanley&rsquo;s Katy L. Huberty maintains an Overweight rating on the company, while raising the price target from $15 to $16.</p> <p>Huberty believes the printer investments will drive EPS growth, going forward.</p> <h3>July Quarter Beat</h3> <p>For the July quarter, the analyst mentioned that outperformance in PCs drove the beat for the quarter, with HP growing 9 points faster than the overall PC market, with flat PC revenue year-on-year.</p> <p><bzrelatedlink>Related Link: ...</bzrelatedlink></p><p><a href=http://www.benzinga.com/analyst-ratings/analyst-color/16/08/8390297/hp-incs-reinvestments-set-up-a-strong-2017 alt=HP Inc&#039;s Reinvestments Set Up A Strong 2017>Full story available on Benzinga.com</a></p> Analyst Color HPQ Katy L. Huberty Long Ideas Morgan Stanley Price Target Analyst Ratings Tech Trading Ideas HPQ US4282361033 Long Ideas Analyst Color Price Target Analyst Ratings Tech Trading Ideas Benzinga Thu, 25 Aug 2016 13:32:30 +0000 Jim Swanson 8390297 at http://www.benzinga.com Valeant's Management Continues To Take The Right Steps http://www.benzinga.com/analyst-ratings/analyst-color/16/08/8390164/valeants-management-continues-to-take-the-right-steps <p>Following meetings with the top management of <b>Valeant Pharmaceuticals Intl Inc</b> (NYSE: <a class="ticker" href="http://www.benzinga.com/stock/vrx#NYSE">VRX</a>), Morgan Stanley&rsquo;s David Risinger expressed confidence that management is &ldquo;taking the right steps to turn the business around and pay down debt.&rdquo;</p> <p>Risinger reiterated an Overweight rating on the company, with a price target of $42.</p> <h3>Growth Drivers</h3> <p>Although the Street has expressed doubts regarding the H2 ramp, management highlighted that both revenue and cost would drive improvement.</p> <p>Regarding revenues, management stated that the growth levers included &ldquo;1) Improving derm revenues due to new Walgreens and prior authorization programs starting in early August, 2) Relistor Oral launch likely in ...</p><p><a href=http://www.benzinga.com/analyst-ratings/analyst-color/16/08/8390164/valeants-management-continues-to-take-the-right-steps alt=Valeant&#039;s Management Continues To Take The Right Steps>Full story available on Benzinga.com</a></p> Analyst Color Biotech David Risinger Long Ideas Morgan Stanley VRX XIFAXAN Health Care Reiteration Analyst Ratings Trading Ideas General VRX CA91911K1021 Long Ideas Analyst Color Biotech Health Care Reiteration Analyst Ratings Trading Ideas General Benzinga Thu, 25 Aug 2016 13:21:54 +0000 Jim Swanson 8390164 at http://www.benzinga.com Don't Use These ETFs To Play Housing Data http://www.benzinga.com/trading-ideas/long-ideas/16/08/8389590/dont-use-these-etfs-to-play-housing-data <p>Investors were enthused earlier this week by some strong housing data. New home sales jumped 12.4 percent in July to a seasonally adjusted rate of 654,000 annual units, well ahead of economists&#39; estimate of 580,000 units.</p> <p>Although the June number was revised lower to 582,000 from 592,000, the July report was enough to send homebuilders stocks and exchange-traded funds, such as the <b>SPDR S&amp;P Homebuilders (ETF) </b>(NYSE: <a class="ticker" href="http://www.benzinga.com/stock/xhb#NYSE">XHB</a>) and the <b>iShares Dow Jones US Home Const. (ETF)</b> (NYSE: <a class="ticker" href="http://www.benzinga.com/stock/itb#NYSE">ITB</a>) soaring.</p> <p> Robust housing data also stoked impressive activity in timber ETFs such as the <b>Claymore/Clear Global Timber Index (ETF)</b> (NYSE: <a class="ticker" href="http://www.benzinga.com/stock/cut#NYSE">CUT</a>) and the <b>iShares S&amp;P Global Timbr &amp; Frstry Idx</b> (NASDAQ: <a class="ticker" href="http://www.benzinga.com/stock/wood#NASDAQ">WOOD</a>).</p> <p><bzrelatedlink>Related Link: <a href="http://www.benzinga.com/top-stories/16/08/8383300/home-sizes-are-now-getting-smaller-here-is-what-you-need-to-know">Home Sizes Are Now Getting Smaller: Here&#039;s What You Need To Know</a></bzrelatedlink></p> <h3>Simplicity Is Not Always The Best Policy</h3> <p>However, investors should be careful before considering CUT and WOOD to ...</p><p><a href=http://www.benzinga.com/trading-ideas/long-ideas/16/08/8389590/dont-use-these-etfs-to-play-housing-data alt=Don&#039;t Use These ETFs To Play Housing Data>Full story available on Benzinga.com</a></p> CUT homebuilders ITB Long Ideas Sector ETFs State Street timber WOOD XHB Commodities Top Stories Markets Trading Ideas ETFs Real Estate CUT US18383Q8794 ITB US4642887529 XHB US78464A8889 WOOD US4642881746 Long Ideas Sector ETFs Commodities Top Stories Markets Trading Ideas ETFs Real Estate Benzinga Thu, 25 Aug 2016 13:05:32 +0000 ETF Professor 8389590 at http://www.benzinga.com Are We There Yet? A Timeline Of The Walgreens-Rite Aid Merger http://www.benzinga.com/news/16/08/8388514/are-we-there-yet-a-timeline-of-the-walgreens-rite-aid-merger <p>Back in October of last year, <b>Walgreens Boots Alliance Inc</b> (NASDAQ: <a class="ticker" href="http://www.benzinga.com/stock/wba#NASDAQ">WBA</a>) announced it would acquire <b>Rite Aid Corporation</b> (NYSE: <a class="ticker" href="http://www.benzinga.com/stock/rad#NYSE">RAD</a>) for $9.00 per share and expected to complete the deal sometime in the second half of 2016. Although the second half of 2016 has already started, shares of Rite Aid are trading only at $7.47, reflecting investors doubts on the original agreement.</p> <p><bzrelatedlink>Related Link: <a href="http://www.benzinga.com/general/biotech/16/08/8383546/risk-arbitrage-trading-strategies">Risk Arbitrage Trading Strategies</a></bzrelatedlink></p> <p>The stock is trading at about a 17.5 percent discount to Walgreen&rsquo;s original offer. Below is a timeline of Walgreen&rsquo;s Rite Aid deal, highlighting the deal&rsquo;s recent developments.</p> <p> <li><strong>August, 24, 2016:</strong> Rumors indicated <b>The Kroger Co</b> (NYSE: <a class="ticker" href="http://www.benzinga.com/stock/kr#NYSE">KR</a>) ...</li></p><p><a href=http://www.benzinga.com/news/16/08/8388514/are-we-there-yet-a-timeline-of-the-walgreens-rite-aid-merger alt=Are We There Yet? A Timeline Of The Walgreens-Rite Aid Merger>Full story available on Benzinga.com</a></p> FTC KR NY Post RAD WBA M&A Movers Media Trading Ideas KR US5010441013 RAD US7677541044 WBA M&A Movers Media Trading Ideas Benzinga Thu, 25 Aug 2016 12:54:38 +0000 Andrew Efimoff 8388514 at http://www.benzinga.com William Blair Upgrades Netflix, Sees 50% Upside: 'Advantage In Original Content & Millennials Underappreciated' http://www.benzinga.com/analyst-ratings/analyst-color/16/08/8390413/william-blair-upgrades-netflix-sees-50-upside-advantage- <p> William Blair&rsquo;s Ralph Schackart believes that despite the volatile period of price increases for <b>Netflix, Inc.</b> (NASDAQ: <a class="ticker" href="http://www.benzinga.com/stock/nflx#NASDAQ">NFLX</a>) shares, the long term risk/reward is favorable, while the stock has upside potential of about 50 percent.</p> <p> Schackart upgraded the rating on the company to Outperform.</p> <h3> Survey Results</h3> <p> A proprietary survey by William Blair suggests the potential of the millennial demographic shift to reach Netflix&rsquo;s long-term domestic subscriber target of 60-90 million is possibly being underappreciated.</p> <p> &ldquo;Despite concerns about domestic subscribers in the recent quarter, we believe that Netflix will benefit as its 70 million-plus audience of nonpaying, often younger users transition to ages at which they become more likely to pay for Netflix,&rdquo; Schackart mentioned.</p> <p> <bzrelatedlink><span>Related Link: </span><a ...</bzrelatedlink></p><p><a href=http://www.benzinga.com/analyst-ratings/analyst-color/16/08/8390413/william-blair-upgrades-netflix-sees-50-upside-advantage- alt=William Blair Upgrades Netflix, Sees 50% Upside: &#039;Advantage In Original Content &amp; Millennials Underappreciated&#039;>Full story available on Benzinga.com</a></p> Analyst Color Long Ideas NFLX Ralph Schackart William Blair Upgrades Top Stories Analyst Ratings Tech Trading Ideas NFLX US64110L1061 Long Ideas Analyst Color Upgrades Top Stories Analyst Ratings Tech Trading Ideas Benzinga Thu, 25 Aug 2016 12:54:19 +0000 Jim Swanson 8390413 at http://www.benzinga.com Why Did The Street Cheer News Of Tableau Software's New CEO? http://www.benzinga.com/trading-ideas/long-ideas/16/08/8389337/why-did-the-street-cheer-news-of-tableau-softwares-new-ceo <p>Shares of <strong>Tableau Software Inc </strong>(NYSE: <a class="ticker" href="http://www.benzinga.com/stock/data#NYSE">DATA</a>)&#039;s spiked more than 10 percent after announcing the appointment of <strong>Amazon.com, Inc. </strong>(NASDAQ: <a class="ticker" href="http://www.benzinga.com/stock/amzn#NASDAQ">AMZN</a>) former executive Adam Selipsky as its new CEO.</p> <p>But, not only investors were cheering the new chief executive; analysts were also pleased with the announcement. On Tuesday, Baird said it was &quot;incrementally positive&quot; on the stock, as its experts believe the CEO pick will help the company boost its Enterprise G2M. The firm reiterated an Outperform rating on the stock, while raising its price target by $5 to $65.</p> <h3>Who&rsquo;s Selipsky?</h3> <p>Selipsky served as Amazon Web Services&rsquo; vice president of marketing, sales and support, having spent more than ...</p><p><a href=http://www.benzinga.com/trading-ideas/long-ideas/16/08/8389337/why-did-the-street-cheer-news-of-tableau-softwares-new-ceo alt=Why Did The Street Cheer News Of Tableau Software&#039;s New CEO?>Full story available on Benzinga.com</a></p> Adam Selipsky AMZN AWS Baird Christian Chabot cloud cloud computing cloud technology DATA Long Ideas News RealNetworks Management Movers Tech Media Trading Ideas AMZN US0231351067 DATA US87336U1051 Long Ideas News Management Movers Tech Media Trading Ideas Benzinga Thu, 25 Aug 2016 12:44:44 +0000 Javier Hasse 8389337 at http://www.benzinga.com Dollar Stores Post Q2 Miss, Shares Fall http://www.benzinga.com/news/earnings/16/08/8390307/dollar-stores-post-q2-miss-shares-fall <p> <strong>Dollar General Corporation</strong> (NYSE: <a class="ticker" href="http://www.benzinga.com/stock/dg#NYSE">DG</a>) and <strong>Dollar Tree, Inc.</strong> (NASDAQ: <a class="ticker" href="http://www.benzinga.com/stock/dltr#NASDAQ">DLTR</a>) reported earnings and revenue miss for the second quarter. Both companies&#39; EPS missed by a penny. As a result, shares of both the companies are hammered in pre-market trading.</p> <p> Dollar General traded down by $7.68, or 8.37 percent, to $84.11; Dollar Tree dropped $5.83, or 6.14 percent, to $89.10.</p> <h3> Dollar General</h3> <p> Dollar General said net income was $307 million, or $1.08 per share, in the second quarter, up from $282 million, or $0.95 per share, in the previous year period. Street analysts expected an EPS of $1.09.</p> <p> Net sales grew 5.8 percent from $5.1 billion to $5.39 billion and came below analysts&#39; predictions of $5.5 billion. ...</p><p><a href=http://www.benzinga.com/news/earnings/16/08/8390307/dollar-stores-post-q2-miss-shares-fall alt=Dollar Stores Post Q2 Miss, Shares Fall>Full story available on Benzinga.com</a></p> DG DLTR Earnings News Guidance Pre-Market Outlook Movers Trading Ideas DLTR US2567461080 DG US2566771059 News Earnings Guidance Pre-Market Outlook Movers Trading Ideas Benzinga Thu, 25 Aug 2016 12:44:35 +0000 R. Chandrasekaran 8390307 at http://www.benzinga.com